ChiCTR2300076443 版本V1.1 版本创建时间2024/03/16 16:30:25 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300076443 

最近更新日期:

Date of Last Refreshed on:

2023-10-09 10:18:38 

注册时间:

Date of Registration:

2023-10-09 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

蠕形螨性睑缘炎不同治疗方案疗效对比研究

Public title:

Comparative study of therapeutic effect of different treatment schemes for demodex blepharitis

注册题目简写:

English Acronym:

研究课题的正式科学名称:

蠕形螨性睑缘炎不同治疗方案疗效对比研究

Scientific title:

Comparative study of therapeutic effect of different treatment schemes for demodex blepharitis

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王浩宇 

研究负责人:

曾庆延 

Applicant:

Wang Haoyu 

Study leader:

Zeng Qingyan 

申请注册联系人电话:

Applicant telephone:

+86 135 4536 4850

研究负责人电话:

Study leader's
telephone:

+86 139 7100 9610

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

155260630@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zengqingyan1972@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

武汉市江汉区马场路328号

研究负责人通讯地址:

武汉市江汉区马场路328号

Applicant address:

328 Machang Road, Jianghan District, Wuhan

Study leader's address:

328 Machang Road, Jianghan District, Wuhan

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

武汉爱尔眼科汉口医院

Applicant's institution:

Hankou Aier Eye Hospital

研究负责人所在单位:

武汉爱尔眼科汉口医院

Affiliation of the Leader:

Hankou Aier Eye Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

HKAIER2023IRB-001-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

武汉爱尔眼科医院汉口医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Hankou Aier Eye Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2023-03-02 00:00:00

伦理委员会联系人:

刘俊杰

Contact Name of the ethic committee:

Liu Junjie

伦理委员会联系地址:

武汉市江汉区马场路328号

Contact Address of the ethic committee:

328 Machang Road, Jianghan District, Wuhan

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 150 7242 9653

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

武汉爱尔眼科汉口医院

Primary sponsor:

Hankou Aier Eye Hospital

研究实施负责(组长)单位地址:

武汉市江汉区马场路328号

Primary sponsor's address:

328 Machang Road, Jianghan District, Wuhan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北省

市(区县):

武汉市

Country:

China

Province:

Hubei

City:

Wuhan

单位(医院):

汉口爱尔眼科医院

具体地址:

武汉市江汉区马场路328号

Institution
hospital:

Hankou Aier Eye Hospital

Address:

328 Machang Road, Jianghan District, Wuhan

经费或物资来源:

由本研究医院提供

Source(s) of funding:

Provided by the study hospital

研究疾病:

睑缘炎  

Target disease:

blepharitis

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

上市后药物 

Study phase:

4

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

蠕形螨是一种人体永久性寄生螨,分别寄居于睫毛囊及皮脂腺内,根据寄居部位分为毛囊蠕形螨及皮脂蠕形螨。蠕形螨通过进出毛囊与皮脂腺活动,可携带细菌,破坏眼表微环境,引起睑缘出现炎性病变,另睑缘炎症反应可累及睑板腺及开口区,导致睑板腺脂质的产生及排出障碍,最终可发展为睑板腺功能障碍等眼表疾病。本研究旨在观察不同治疗方案对蠕形螨感染所致相关眼表疾病的治疗效果  

Objectives of Study:

Demodex is a kind of permanent parasitic mite in human body. It resides in ciliary hair follicles and sebaceous glands respectively, and can be divided into Demodex follicularis and Demodex sebaceous according to the residence site. Demodemoid mites can carry bacteria through the movement in and out of hair follicles and sebaceous glands, destroy the microenvironment of the ocular surface, and cause the inflammatory lesions of the palpebral margin. The inflammatory reaction of the other palpebral margin can involve the meibomian glands and the opening area, resulting in the production and excretion of meibomian glands lipids, and eventually the development of meibomian gland dysfunction and other ocular surface diseases. The objective of this study was to observe the effect of different treatment regimens on ocular surface diseases caused by demodex infection

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

符合蠕形螨睑缘炎诊断标准:
1、双眼慢性或亚急性病程,有眼红、眼痒、异物感等眼部症状或伴有反复发作、难治性霰粒肿。
2、睫毛异常,睫毛根部脂样袖套状分泌物(具有诊断提示价值),可伴有睑缘充血和肥厚。3.蠕形螨检查阳性。
毛囊蠕形螨检查阳性推荐标准:(1)各期的蠕形螨均计数在内;(2)成人患者在4个眼睑中的任1个眼睑蠕形螨计数达到3条/3根睫毛;(3)小于上述标准为可疑阳性,需结合临床表现,必要时可同时进行其他病原微生物的检查,如细菌、真菌等。同时符合以上3条,可确诊蠕形螨睑缘炎。同时符合前两条,睫毛检出蠕形螨但计数达不到标准,可重复取材及应用活体激光共聚焦显微镜辅助检查;若计数仍达不到标准,可诊断为疑似蠕形螨睑缘炎。仅蠕形螨检出阳性而无临床症状和体征者不诊断蠕形螨睑缘炎

Inclusion criteria

Meet the diagnostic criteria of demodex blepharitis:
1. Chronic or subacute course of binocular disease, with eye symptoms such as red eyes, itching eyes, foreign body sensation, or accompanied by recurrent attacks and refractory chalazion.
2. Abnormal eyelashes, lipid-cuff secretions at the root of eyelashes (with diagnostic value), can be accompanied by blepharon congestion and hypertrophy. 3. Demodex was tested positive.
Recommended criteria for positive Demodex follicularis test: (1) Demodex counts in all stages; (2) In adult patients, demodex counts reached 3 /3 eyelashes in any one of the 4 eyelids; (3) If it is less than the above criteria, it is suspected to be positive, which should be combined with clinical manifestations. If necessary, other pathogenic microorganisms, such as bacteria and fungi, can be examined at the same time. If the above three criteria are met at the same time, the diagnosis of demodex blepharitis can be confirmed. If demodex mites are detected in eyelashes but the count is not up to the standard, the samples can be taken repeatedly and the in vivo confocal laser microscope can be used for auxiliary examination. If the count is still not up to the standard, it can be diagnosed as suspected demodex blepharitis. Demodex blepharitis is not diagnosed only in patients with positive demodex without clinical symptoms and signs

排除标准:

(1)患有全身免疫性疾病者;(2)近期眼部急性感染病史,(3)不能够理解、不能配合治疗者(4)全身严重疾病不耐受治疗者;(5)妊娠及哺乳者

Exclusion criteria:

(1) Patients with systemic immune diseases; (2) recent history of acute eye infection, (3) patients who cannot understand or cooperate with treatment, (4) patients with systemic severe disease intolerance to treatment; (5) Pregnancy and breastfeeding

研究实施时间:

Study execute time:

From 2023-10-09 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-10-10 00:00:00 To 2023-10-31 00:00:00

干预措施:

Interventions:

组别:

实验组

样本量:

20

Group:

experimental group

Sample size:

干预措施:

睑缘深度清洁+4-松油醇湿巾

干预措施代码:

Intervention:

micro blepharo exfoliation+terpinen-4-ol lid wipes

Intervention code:

组别:

对照组

样本量:

20

Group:

control group

Sample size:

干预措施:

4-松油醇湿巾

干预措施代码:

Intervention:

terpinen-4-ol lid wipes

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖北省 

市(区县):

武汉市 

Country:

China

Province:

Hubei

City:

单位(医院):

武汉爱尔眼科汉口医院 

单位级别:

三级 

Institution
hospital:

Hankou Aier Eye Hospital

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

睑缘蠕形螨数量

指标类型:

主要指标

Outcome:

Demodex load

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

睑缘体征

指标类型:

主要指标

Outcome:

Palpebral sign

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

眼表症状评分

指标类型:

次要指标

Outcome:

Eye surface symptom score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

眼表体征

指标类型:

次要指标

Outcome:

Eye surface signs

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

睑板腺脂质

组织:

Sample Name:

palpebral sebum

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

研究人员王浩宇使用Stata软件进行简单随机化分组

Randomization Procedure (please state who generates the random number sequence and by what method):

Researcher Haoyu Wang used Stata software to simply randomize the groups

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

双盲

Blinding:

double blind

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2024年12月前公布于http://www.aieryk.com/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Posted at http://www.aieryk.com/ by December 2024

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-10-09 10:18:08